Related Experiment Videos
Mesenteric venous thrombosis and oral contraceptives
Southern Medical Journal
|March 1, 1977
Summary
Oral contraceptives may increase the risk of developing mesenteric venous thrombosis, a serious condition affecting blood flow in the abdomen. This finding suggests a potential link that warrants further investigation in women using these medications.
Area of Science:
- Vascular Surgery
- Gastroenterology
- Pharmacology
Background:
- Oral contraceptives are widely prescribed hormonal medications.
- Mesenteric venous thrombosis (MVT) is a rare but severe vascular emergency.
- Previous case reports have suggested a possible association between oral contraceptives and MVT.
Observation:
- A 46-year-old woman developed mesenteric venous thrombosis after six years of oral contraceptive use.
- This case adds to a reported series of 17 similar cases in young women using oral contraceptives.
Findings:
- The presented case and existing literature suggest a potential association between oral contraceptive agents and the development of mesenteric venous thrombosis.
- The risk appears to be higher in young women using these medications.
Implications:
- Healthcare providers should consider MVT in the differential diagnosis for abdominal pain in women using oral contraceptives.
- Further research is warranted to elucidate the causal relationship and underlying mechanisms.
- This highlights the importance of pharmacovigilance for hormonal contraceptives.